Ligayan, Rosalie P.
HRN: 26-20-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/21/2024
11/28/2024
IV
4.5g
Q8
Purulent Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes